{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T17:19:43Z","timestamp":1758043183588,"version":"3.44.0"},"reference-count":26,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T00:00:00Z","timestamp":1757635200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:p>We report a 52-year-old man with autoantibody-negative type 1 diabetes (T1D) who presented with severe insulin resistance (IR). Whole-exome sequencing (WES) identified a heterozygous mutation in the IGF2BP2 gene (c.248A&amp;gt;G, p. Lys83Thr; rs4402960), associated with type 2 diabetes (T2D) risk. Despite intensive insulin therapy, the patient exhibited markedly elevated insulin requirements (&amp;gt;1.5 U\/kg\/day; total, 140 U\/day) alongside persistent hyperglycemia. The estimated glucose disposal rate (eGDR) was 4.32 mg\/kg\/min, indicating significant IR. The Somogyi phenomenon was ruled out via continuous glucose monitoring (CGM), and the patient was deemed to have IR. The addition of metformin, acarbose, and dapagliflozin reduced insulin requirements and significantly improved glycemic control. This case suggests that T2D-associated genetic variants may contribute to IR in T1D and underscores the potential value of genetic testing in guiding targeted oral combination therapy.<\/jats:p>","DOI":"10.3389\/fendo.2025.1656453","type":"journal-article","created":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T04:15:12Z","timestamp":1757650512000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Case Report: Insulin resistance in type 1 diabetes mellitus: the role of genetic factors"],"prefix":"10.3389","volume":"16","author":[{"given":"Jintao","family":"Wei","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shi-Yuan","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tianyue","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2025,9,12]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/S0140-6736(13)60591-7","article-title":"Type 1 diabetes","volume":"383","author":"Atkinson","year":"2014","journal-title":"Lancet"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2024.06.029","article-title":"Diabetes mellitus-Progress and opportunities in the evolving epidemic","volume":"187","author":"Abel","year":"2024","journal-title":"Cell"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2019.00661","article-title":"Prevalence of metabolic syndrome and its determinants in newly-diagnosed adult-onset diabetes in China: A multi-center, cross-sectional survey","volume":"10","author":"Li","year":"2019","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1002\/jcp.31419","article-title":"Mechanisms of insulin resistance in type 1 diabetes mellitus: A case of glucolipotoxicity in skeletal muscle","volume":"239","author":"Sammut","year":"2024","journal-title":"J Cell Physiol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1186\/s12933-024-02145-x","article-title":"Double\u00a0diabetes-when type 1 diabetes meets type 2 diabetes: definition, pathogenesis\u00a0and recognition","volume":"23","author":"Bielka","year":"2024","journal-title":"Cardiovasc Diabetol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1126\/science.1142364","article-title":"Replication of genome-wide association signals in UK samples reveals risk loci for type 2 diabetes","volume":"316","author":"Zeggini","year":"2007","journal-title":"Science"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1042\/BSR20193955","article-title":"Influence of IGF2BP2, HMG20A, and HNF1B genetic polymorphisms on the susceptibility to Type 2 diabetes mellitus in Chinese Han population","volume":"40","author":"Huang","year":"2020","journal-title":"Biosci Rep"},{"key":"B8","doi-asserted-by":"publisher","first-page":"e13814","DOI":"10.1002\/jcsm.13814","article-title":"Estimated glucose disposal rate associated with risk of frailty and likelihood of reversion","volume":"16","author":"Hou","year":"2025","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.31557\/APJCP.2021.22.9.2889","article-title":"Relationship between consulting for second medical opinions, radiotherapy, and satisfaction with therapy, analyzed by structural equation modeling: A web-based survey","volume":"22","author":"Minamitani","year":"2021","journal-title":"Asian Pac J Cancer Prev"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgad022","article-title":"GLP-1 receptor agonists and SGLT-2 inhibitors as adjuncts to insulin in type 1 diabetes: benefits and concerns","volume":"108","author":"Dimitriadis","year":"2023","journal-title":"J Clin Endocrinol Metab"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1111\/dom.13439","article-title":"Short-term effects of dapagliflozin on insulin sensitivity, postprandial glucose excursion and ketogenesis in type 1 diabetes mellitus: A randomized, placebo-controlled, double blind, cross-over pilot study","volume":"20","author":"Melmer","year":"2018","journal-title":"Diabetes Obes Metab"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.2337\/diabetes.49.4.626","article-title":"Can clinical factors estimate insulin resistance in type 1 diabetes","volume":"49","author":"Williams","year":"2000","journal-title":"Diabetes"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.2337\/dbi19-0026","article-title":"The peripheral peril: injected insulin induces insulin insensitivity in type 1 diabetes","volume":"69","author":"Gregory","year":"2020","journal-title":"Diabetes"},{"key":"B14","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.pcad.2024.01.003","article-title":"Update on obesity, the obesity paradox, and obesity management in heart failure","volume":"82","author":"Alebna","year":"2024","journal-title":"Prog Cardiovasc Dis"},{"key":"B15","doi-asserted-by":"publisher","first-page":"7476","DOI":"10.1038\/s41598-020-64493-4","article-title":"Integrative analysis of Mendelian randomization and Bayesian colocalization highlights four genes with putative BMI-mediated causal pathways to diabetes","volume":"10","author":"Liu","year":"2020","journal-title":"Sci Rep"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1210\/endrev\/bnae032","article-title":"Insulin resistance in type 1 diabetes: pathophysiological, clinical, and therapeutic relevance","volume":"46","author":"Apostolopoulou","year":"2025","journal-title":"Endocr Rev"},{"key":"B17","doi-asserted-by":"publisher","first-page":"2569","DOI":"10.1038\/s41467-025-57452-y","article-title":"Heterogeneous effects of genetic variants and traits associated with fasting insulin on cardiometabolic outcomes","volume":"16","author":"Sevilla-Gonz\u00e1lez","year":"2025","journal-title":"Nat Commun"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1111\/pedi.12166","article-title":"A decade of temporal trends in overweight\/obesity in youth with type 1 diabetes after the Diabetes Control and Complications Trial","volume":"16","author":"Baskaran","year":"2015","journal-title":"Pediatr Diabetes"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-008-1083-z","article-title":"Variants of CDKAL1 and IGF2BP2 affect first-phase insulin secretion during hyperglycaemic clamps","volume":"51","author":"Groenewoud","year":"2008","journal-title":"Diabetologia"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1016\/j.tem.2020.05.007","article-title":"The diverse functions of IMP2\/IGF2BP2 in metabolism","volume":"31","author":"Dai","year":"2020","journal-title":"Trends Endocrinol Metab"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.7326\/M23-2788","article-title":"Newer pharmacologic treatments in adults with type 2 diabetes: A clinical guideline from the american college of physicians","volume":"177","author":"Qaseem","year":"2024","journal-title":"Ann Intern Med"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-20-1121","article-title":"The role of GLP-1 in the postprandial effects of acarbose in type 2 diabetes","volume":"184","author":"Dalsgaard","year":"2021","journal-title":"Eur J Endocrinol"},{"key":"B23","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1093\/ejendo\/lvae095","article-title":"The role of glucagon-like peptide 1 in the postprandial effects of metformin in type 2 diabetes: a randomized crossover trial","volume":"191","author":"Hansen","year":"2024","journal-title":"Eur J Endocrinol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.2337\/dc18-1569","article-title":"The SGLT2 inhibitor dapagliflozin reduces liver fat but does not affect tissue insulin sensitivity: A randomized, double-blind, placebo-controlled study with 8-week treatment in type 2 diabetes patients","volume":"42","author":"Latva-Rasku","year":"2019","journal-title":"Diabetes Care"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-009-1636-9","article-title":"The use of metformin in type 1 diabetes: a systematic review of efficacy","volume":"53","author":"Vella","year":"2010","journal-title":"Diabetologia"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1016\/0026-0495(85)90010-1","article-title":"alpha-Glucosidase inhibition improves postprandial hyperglycemia and decreases insulin requirements in insulin-dependent diabetes mellitus","volume":"34","author":"Dimitriadis","year":"1985","journal-title":"Metabolism"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2025.1656453\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T04:15:14Z","timestamp":1757650514000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2025.1656453\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,12]]},"references-count":26,"alternative-id":["10.3389\/fendo.2025.1656453"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2025.1656453","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,12]]},"article-number":"1656453"}}